Peptides after surgery: the evidence

Someone recovering from elective facial surgery asked a peptide forum a reasonable question: having paused BPC-157, GHK-Cu and KPV a week before the operation, when is it safe to start again? The honest answer is that nobody knows, and the reason is not caution. No human trial has measured what any of these three peptides does to a surgical wound, so there is no evidence base from which a restart window could be worked out.

The second half of that question is better founded. Inflammation really is part of healing rather than an obstacle to it, and the worry about healing too fast is not silly. It is just more complicated than the forum version.

Inflammation is a stage of healing, not a side effect

Healing is usually described as four sequenced phases: hemostasis, inflammation, proliferation and remodelling. A widely cited 2010 review in the Journal of Dental Research puts the requirement plainly: for a wound to heal successfully, all four phases must occur in the proper sequence and time frame^[1]. The inflammatory phase is where immune cells clear debris and bacteria and where the signalling that drives the next phase gets set up. Skipping it is not a shortcut.

The common failure runs in the other direction. A 2021 review in Biomolecules describes how dysregulation of the immune system during the healing process leads to persistent inflammation and delayed healing, the pattern seen in chronic wounds^[2]. Inflammation that will not switch off is the recognised clinical problem. Healing at an unusually fast rate is not a described complication of soft-tissue surgery.

What about deliberately damping inflammation after an operation? That has been studied for orthopaedic surgery, and the answer is genuinely unsettled. A 2019 systematic review with meta-analysis in the Iowa Orthopaedic Journal concluded that the current literature does not provide sufficient evidence for or against the use of anti-inflammatory drugs following acute injury or surgical repair of the tendon-bone interface^[3]. That is where the evidence sits for a drug class with decades of clinical use and registered trials behind it. The three peptides in question have nothing approaching that.

What the research actually shows for these three peptides

BPC-157 has the largest research base of the three and it is still almost entirely preclinical. A 2025 systematic review in HSS Journal screened 544 articles and included 36 studies of BPC-157 in orthopaedic sports medicine: 35 preclinical, and one small retrospective clinical review of 12 patients with knee pain^[4]. The authors describe the compound as showing promise while warning that adverse effects are possible due to unregulated manufacturing, contamination, or unknown clinical safety. The US Department of Defense Operation Supplement Safety programme is blunter, stating that BPC-157 is an unapproved drug that cannot be legally prescribed or sold over the counter and that there is little to no reliable scientific evidence to support its safety or effectiveness in humans^[5]. Per-country status is on the BPC-157 regulatory section.

GHK-Cu, a copper-binding tripeptide, has the single most relevant surgical result of the three, and it is a cautionary one. A 2015 study in the Journal of Orthopaedic Research gave GHK-Cu into the joint of rats after ACL reconstruction. Treated animals showed a smaller side-to-side difference in knee laxity at 6 weeks, but the authors reported that the beneficial effects could not last as treatment discontinued: no significant differences remained at 12 weeks, and ultimate load, gait function and histological scores did not improve^[6]. That is a rat model of a different operation, and even there the effect faded.

KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone with documented anti-inflammatory activity in animals. The most-cited work is a 2008 paper in Inflammatory Bowel Diseases reporting significant anti-inflammatory effects in two murine models of colitis^[7]. Colitis is not a surgical wound, and there is no published human trial of KPV for post-operative recovery. Worth sitting with the irony: the peptide is being taken to speed healing, and what it is documented to do in mice is suppress the inflammatory response that the healing sequence depends on.

Why an easy recovery is not evidence the peptides worked

The original post included a detail worth taking seriously: minimal pain, minimal swelling, no painkillers needed after buccal fat pad removal. The writer had stopped all three peptides a week before surgery, which means the peptides were absent during the operation and during the entire recovery being described. Crediting them requires a carryover effect that nobody has measured. There is also a baseline problem. A 2021 systematic review in Medicina Oral Patologia Oral y Cirugia Bucal found buccal fat pad removal had a low postoperative complication rate, 7 complications across 134 procedures, while noting that much of the published work uses poor methodology and that long-term follow-up data is missing^[8]. An uneventful recovery from this procedure is the ordinary outcome, not the surprising one.

What we do not yet know

The gaps here are the whole picture. Nobody has measured what BPC-157, GHK-Cu or KPV do to a healing surgical wound in a human, at any dose, by any route. Nobody has characterised how an anti-inflammatory peptide interacts with the inflammatory phase healing depends on, or whether timing relative to the operation changes anything. Nobody knows how the three interact with anaesthetics, antibiotics or post-operative analgesics. And because none of them is an approved medicine, what is actually in a given vial is a separate unknown from what the molecule does. The same holds for TB-500 and the other repair peptides that circulate in the same threads.

If you are recovering from an operation, the person who should answer the restart question is the surgeon who performed it. They know the wound, the closure and your complication risks, and they are the only party in this equation holding information specific to you. This article is educational and is not medical advice. Consult a qualified healthcare professional before using any peptide product, and especially before using one around surgery.